FDA Approves Telix's Pixclara for Brain Tumor Imaging

The FDA has approved Telix's Pixclara (floretyrosine F 18), an amino acid PET drug, for imaging gliomas (brain cancer). This is the first FDA-approved FET-PET imaging drug for glioma, addressing a critical need by helping physicians distinguish recurrent or progressive glioma from treatment-related changes in both adult and pediatric patients.